ZeClinics has been awarded with CIR acreditation

This is good news for our customers based in France, who from now on will be able to claim tax relief of 30-50% on R&D costs.

ZeClinics is pleased to announce that it has been awarded with a new CIR accreditation from the French Ministère de l'Enseignement supérieur, de la Recherche et de l'Innovation. This is good news for our customers based in France, who from now on will be able to claim tax relief of 30-50% on R&D costs from projects outsourced to ZeClinics. Our CIR accreditation, part of the French Research Tax Credit Scheme, is valid until 2020 and works as an incentive for firms who are subject to corporate tax in France to increase their R&D expenditure. We at ZeClinics celebrate being able to provide quality preclinical services as well as access to such tax benefits. ---------------------------------------------------------------------------------------------------------------- L'accréditation CIR (crédit d'impôt recherche), qui permet le soutien aux activités de recherche et développement des entreprises, est valable jusqu'en 2020. Cet agrément permet aux entreprises, qui sont soumises à l'impôt sur les sociétés, à augmenter leurs dépenses R&D. Chez ZeClinics, nous sommes ravis de pouvoir vous offrir des études précliniques de qualité, et vous permettre de bénéficier des avantages fiscaux associés au label CIR.